http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100854542-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fbb92fa410280fa662c67c94207ca38
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
filingDate 2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e969e49e2522b4fe1d7a05bdbb3bb03c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_312bb7776a2b7ea0cec3114bfc31bac8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1b5abc322bcf4b102c73e603851318c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c4ec12b187d2bc262ca17c9f9d81bd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16045f2fc92386462c0e47dbe65c88b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f03ea519b3e0ed89fb006499ebc824e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d44b12f51ac47142700005a9cc392ac1
publicationDate 2008-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100854542-B1
titleOfInvention Antithrombotic pharmaceutical composition containing cilostazol and aspirin and preparation method thereof
abstract The present invention relates to an anti-thrombotic pharmaceutical composition comprising cilostazol and aspirin and a method for preparing the same, and in particular, an anti-thrombotic pharmaceutical composition having an effective dosage form that can minimize side effects and increase the efficacy even at a low dosage, and a method for preparing the same. It is about. In the present invention, (a) 1 part by weight of aspirin enteric polymer coated with 0.01 to 0.4 parts by weight of enteric polymers; (b) 1.5 to 2.5 parts by weight of cilostazol, and then coated with 0.01 to 0.4 parts by weight of a water-soluble polymer, a cilostazol water-soluble polymer coating pellet is provided. The composition of the present invention is to separate the coating cilostazol and aspirin in one formulation so that the cilostazole in the composition is released in the stomach to act on the small intestinal mucosa and aspirin is released in the intestine to act on the intestine, It prevents the action and maximizes the expression of the drug. In addition, the composition of the present invention improves the stability of each component, minimizes side effects, and the drug efficacy is increased even at a lower dosage than when each drug is administered.
priorityDate 2007-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006003002-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002058066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070021830-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20070021829-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449000177
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407932856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414042168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID181977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591227
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505428
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21948654
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242

Total number of triples: 56.